Assyro AI

FDA Orange Book · active-ingredient family

Hydroxocobalamin

Hydroxocobalamin is approved as 1 brand and 5 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:CYANOKIT · NDA 022041

1

Brand (NDA)

5

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · injectable

ProductApplicantApplicationTEApproved
CYANOKITRLD×2BTG INTLNDA 022041Apr 08, 2011

Generic (ANDA) products (5)

ProductApplicantApplicationTEApproved
ALPHAREDISOLMERCKANDA 080778Approved Prior to Jan 1, 1982
HYDROXOCOBALAMINABRAXIS PHARMANDA 084921Approved Prior to Jan 1, 1982
HYDROXOCOBALAMINACTAVISANDA 085998Approved Prior to Jan 1, 1982
HYDROXOCOBALAMINWATSON LABSANDA 085528Approved Prior to Jan 1, 1982
HYDROXOMINBEL MARANDA 084629Approved Prior to Jan 1, 1982

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Hydroxocobalamin — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.